Search results for "Hippo pathway"
showing 4 items of 4 documents
Repurposing of Drugs Targeting YAP-TEAD Functions
2018
Drug repurposing is a fast and consolidated approach for the research of new active compounds bypassing the long streamline of the drug discovery process. Several drugs in clinical practice have been reported for modulating the major Hippo pathway’s terminal effectors, namely YAP (Yes1-associated protein), TAZ (transcriptional co-activator with PDZ-binding motif) and TEAD (transcriptional enhanced associate domains), which are directly involved in the regulation of cell growth and tissue homeostasis. Since this pathway is known to have many cross-talking phenomena with cell signaling pathways, many efforts have been made to understand its importance in oncology. Moreover, this could be rele…
The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the …
2021
Aim Arrhythmogenic cardiomyopathy (ACM) is a primary myocardial disease that typically manifests with cardiac arrhythmias, progressive heart failure and sudden cardiac death (SCD). ACM is mainly caused by mutations in genes encoding desmosome proteins. Desmosomes are cell-cell adhesion structures and hubs for mechanosensing and mechanotransduction. The objective was to identify the dysregulated molecular and biological pathways in human ACM in the absence of overt heart failure. Methods and results Transcriptomes in the right ventricular endomyocardial biopsy samples from three independent individuals carrying truncating mutations in the DSP gene and 5 control samples were analyzed by RNA-S…
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer
2020
The role of Hippo pathway in colorectal cancer (CRC) initiation and progression has been controversial. In this issue of Cell Stem Cell, Cheung et al. (2020) shed new light on a distinct function of the transcriptional co-activator YAP as a tumor suppressor and Wnt pathway inhibitor in CRC.
DIVERSIFICATION OF HIPPO SIGNALING COMPONENTS IN SELECTED METAZOAN SPECIES
La via di segnalazione intracellulare conosciuta come Hippo pathway svolge un ruolo chiave nei processi che regolano il controllo della dimensione degli organi, la proliferazione, l’apoptosi, il mantenimento delle caratteristiche di staminalità cellulare. Alterazioni nel pathway sono state descritte in molti tipi di tumori. Il nome deriva da una delle sue componenti principali, la proteina chinasi Hippo (Hpo), identificata per la prima volta in Drosophila melanogaster. Mutazioni nel gene Hpo inducevano la crescita abnorme di tessuti e organi. Componenti del pathway Hippo sono stati successivamente individuati anche nei mammiferi. Gli elementi fondamentali sono costituiti dalla proteine chin…